JP2019520342A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520342A5
JP2019520342A5 JP2018563040A JP2018563040A JP2019520342A5 JP 2019520342 A5 JP2019520342 A5 JP 2019520342A5 JP 2018563040 A JP2018563040 A JP 2018563040A JP 2018563040 A JP2018563040 A JP 2018563040A JP 2019520342 A5 JP2019520342 A5 JP 2019520342A5
Authority
JP
Japan
Prior art keywords
formula
conjugate
ring
present
binding site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2018563040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520342A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/063447 external-priority patent/WO2017207754A1/en
Publication of JP2019520342A publication Critical patent/JP2019520342A/ja
Publication of JP2019520342A5 publication Critical patent/JP2019520342A5/ja
Ceased legal-status Critical Current

Links

JP2018563040A 2016-06-02 2017-06-02 グルコース感知タンパク質に結合することができる薬剤および部分のコンジュゲート Ceased JP2019520342A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16305640.1 2016-06-02
EP16305640 2016-06-02
PCT/EP2017/063447 WO2017207754A1 (en) 2016-06-02 2017-06-02 Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein

Publications (2)

Publication Number Publication Date
JP2019520342A JP2019520342A (ja) 2019-07-18
JP2019520342A5 true JP2019520342A5 (cg-RX-API-DMAC7.html) 2021-09-24

Family

ID=56121007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018563040A Ceased JP2019520342A (ja) 2016-06-02 2017-06-02 グルコース感知タンパク質に結合することができる薬剤および部分のコンジュゲート

Country Status (13)

Country Link
US (3) US11090364B2 (cg-RX-API-DMAC7.html)
EP (1) EP3463480A1 (cg-RX-API-DMAC7.html)
JP (1) JP2019520342A (cg-RX-API-DMAC7.html)
KR (1) KR20190015413A (cg-RX-API-DMAC7.html)
CN (1) CN109562185A (cg-RX-API-DMAC7.html)
AU (1) AU2017272862A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018074716A2 (cg-RX-API-DMAC7.html)
CA (1) CA3025988A1 (cg-RX-API-DMAC7.html)
IL (1) IL263390A (cg-RX-API-DMAC7.html)
MX (1) MX2018014929A (cg-RX-API-DMAC7.html)
RU (1) RU2018147235A (cg-RX-API-DMAC7.html)
SG (1) SG11201810701XA (cg-RX-API-DMAC7.html)
WO (1) WO2017207754A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018014929A (es) * 2016-06-02 2019-08-26 Sanofi Sa Conjugados de un agente farmaceutico y una porcion capaz de unirse a una proteina sensora de glucosa.
CN111433193A (zh) 2017-12-01 2020-07-17 赛诺菲 药剂和能够结合至葡萄糖传感蛋白的部分的新型缀合物
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Gpr84アンタゴニストおよびその使用
CN115920081B (zh) * 2022-11-02 2024-07-19 重庆大学 红细胞膜自发定向包被ros响应的纳米前药及其应用
WO2025199666A1 (en) * 2024-03-25 2025-10-02 Canwell Biotech Limited Multivalent linkers for high loading antibody-drug conjugates, and compositions and methods thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK111489D0 (da) 1989-03-08 1989-03-08 Novo Nordisk As Peptider
AU2001263775A1 (en) 2000-06-02 2001-12-11 Novo-Nordisk A/S Glucose dependent release of insulin from glucose sensing insulin derivatives
EP1453860A2 (en) 2001-12-02 2004-09-08 Novo Nordisk A/S Novel glucose-dependant insulins
JP2011506442A (ja) * 2007-12-11 2011-03-03 コンジュケム バイオテクノロジーズ インコーポレイテッド インスリン分泌性ペプチド結合体の製剤
FR2929615B1 (fr) 2008-04-02 2010-12-17 Tfchem Composes c-aryl glycosides pour le traitement du diabete et de l'obesite.
CN101638423B (zh) 2008-07-29 2012-09-05 常州高新技术产业开发区三维工业技术研究所有限公司 根皮苷衍生物及其制备方法和用途
AU2009294606A1 (en) 2008-09-19 2010-03-25 Novartis Ag Glycoside derivatives and uses thereof
RU2011135730A (ru) 2009-01-28 2013-03-10 Смартселлз, Инк. Кристаллические инсулин-коньюгаты
WO2010088294A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Conjugate based systems for controlled drug delivery
WO2010107520A1 (en) 2009-03-20 2010-09-23 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
EP2448962B1 (en) 2009-06-30 2016-10-19 Novo Nordisk A/S Insulin derivatives
EP2549863A4 (en) * 2010-03-24 2014-01-01 Univ Ohio COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORTATION
WO2012015681A2 (en) 2010-07-28 2012-02-02 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
JP2013535467A (ja) 2010-07-28 2013-09-12 スマートセルズ・インコーポレイテツド 組換えにより発現されたインスリンポリペプチドおよびその使用
JP2014510782A (ja) 2011-04-14 2014-05-01 ノバルティス アーゲー グリコシド誘導体およびその使用
WO2012177701A2 (en) 2011-06-20 2012-12-27 Radiomedix Inc. Compositions, methods of synthesis and use of carbohydrate targeted agents
CA2864432A1 (en) 2012-02-15 2013-08-22 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
US20150086521A1 (en) 2012-03-21 2015-03-26 Erytech Pharma Medicament for the Treatment of Acute Myeloid Leukemia (AML)
WO2013182612A1 (en) * 2012-06-07 2013-12-12 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
EP2813234A1 (en) 2013-06-11 2014-12-17 Erytech Pharma Composition of erythrocytes encapsulating phenylalanine hydroxylase and therapeutic use thereof
US9884125B2 (en) 2013-10-04 2018-02-06 Merck Sharp & Dohme Corp. Glucose-responsive insulin conjugates
LT3094731T (lt) 2014-01-15 2019-10-25 Baseclick Gmbh Sacharidais modifikuotos nukleorūgšties molekulės
FR3017299B1 (fr) 2014-02-12 2018-05-18 Erytech Pharma Composition pharmaceutique comprenant des erythrocytes encapsulant une enzyme a plp et son cofacteur
CN108778318B (zh) * 2016-01-14 2022-05-03 北卡罗莱纳州立大学 葡萄糖响应性胰岛素递送组合物和方法
MX2018014929A (es) 2016-06-02 2019-08-26 Sanofi Sa Conjugados de un agente farmaceutico y una porcion capaz de unirse a una proteina sensora de glucosa.

Similar Documents

Publication Publication Date Title
Kuijpers et al. Expedient synthesis of triazole-linked glycosyl amino acids and peptides
RU2018147235A (ru) Конъюгаты фармацевтического средства и фрагмента, способного связываться с глюкозочувствительным белком
EP1198254B1 (de) Träger-pharmaka-konjugate
RU2190594C2 (ru) Органические нитраты и фармацевтическая композиция, обладающая ингибирующей агрегацию тромбоцитов активностью, на их основе
JP4392065B2 (ja) 腫瘍および炎症性疾患治療用の新規プロドラッグ
KR950702829A (ko) 신경계 퇴행성 질환의 치료에 유용한 아나바세인 유도체
JP2010502582A5 (cg-RX-API-DMAC7.html)
SG173117A1 (en) Crystalline insulin-conjugates
ATE205725T1 (de) Polymergebundene paclitaxel-derivate
US20210252160A1 (en) Compounds, compositions, methods, and uses for treating cancer and immunological disorders
IE890810L (en) Pharmaceutical formulations for parenteral use
RU2005137360A (ru) Органические соединения
JP2019511497A5 (cg-RX-API-DMAC7.html)
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
DE10310082A1 (de) Protein-bindende Doxorubicin-Peptid-Derivate
WO2002028345A2 (en) Aldehyde-releasing compounds
US11541122B2 (en) Glucose sensitive insulins and uses thereof
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors
CN102391323B (zh) 四氢-β-咔啉衍生物、其制备方法及其用途
CA2411172C (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
RU2005105066A (ru) Новые гем-дифторированные соединения, способы их получения и их применение
Kapoor et al. Bio-active conjugates of curcumin having ester, peptide, thiol and disulfide links
US20070259889A1 (en) Protein Binding Compounds
RU2010137336A (ru) Производное 3,8-диаминотетрагидрохинолина
JP2003212893A (ja) アミド結合型糖鎖含有カルボシランデンドリマーおよびその製造方法